SPOK Spok Holdings registers 51 negative Q1 2026 EPS surprise shares slide 366 in todays trading The biggest catalyst for Evolution EVOXW nobody is watching Modest Uptick 20260508 ESPR Esperion Therapeutics reports Q4 2025 EPS miss shares post small gains even as earnings lag analyst estimates AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks Axalta AXTA Gains 131 Support Holds at 2686 20260514 Is Pursuit PRSU Still a Buy After 159 Rally 20260514 Blackstone27 BSL Stock Consolidating at 1317 Next Move Ahead 20260515 CHRobinson CHRW Q1 2026 Results Top Views on Strong Revenue